Huong T. Kratochvil

Huong T. Kratochvil

Auto-generated profile, based on publicly available information

Huong T. Kratochvil

Department of Chemistry College of Arts and Sciences University of North Carolina at Chapel Hill Chapel Hill North Carolina United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Science
Verified
Journal Article
Open access
PDF file
DGDavid E. Gordon
David E. Gordon
JHJoseph Hiatt
Joseph Hiatt
MBMehdi Bouhaddou
Mehdi Bouhaddou
VRVeronica V. Rezelj
Veronica V. Rezelj
SUSvenja Ulferts
Svenja Ulferts
HLHarris A. Lewin
Harris A. Lewin
How lethal coronaviruses engage hosts: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection. For a subset of the interactions essential for the virus life cycle, the authors determined the cryo–electron microscopy structures and mined patient data to understand how targeting host factors may be relevant to clinical outcomes. Science , this issue p. eabe9403

18 December 2020 in Science
Verified
Journal Article
Open access
PDF file
MSMichael Schoof
Michael Schoof
BFBryan Faust
Bryan Faust
RSReuben A. Saunders
Reuben A. Saunders
SSSmriti Sangwan
Smriti Sangwan
VRVeronica Rezelj
Veronica Rezelj
AMAashish Manglik
Aashish Manglik
Nanobodies that neutralize: Monoclonal antibodies that bind to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show therapeutic promise but must be produced in mammalian cells and need to be delivered intravenously. By contrast, single-domain antibodies called nanobodies can be produced in bacteria or yeast, and their stability may enable aerosol delivery. Two papers now report nanobodies that bind tightly to spike and efficiently neutralize SARS-CoV-2 in cells. Schoof et al. screened a yeast surface display of synthetic nanobodies and Xiang et al. screened anti-spike nanobodies produced by a llama. Both groups identified highly potent nanobodies that lock the spike protein in an inactive conformation. Multivalent constructs of selected nanobodies achieved even more potent neutralization. Science , this issue p. 1473 , p. 1479

2 September 2016 in Science
Verified
Journal Article
Closed access
PDF file
HKHuong T. Kratochvil
Huong T. Kratochvil
JCJoshua K. Carr
Joshua K. Carr
KMKimberly Matulef
Kimberly Matulef
AAAlvin W. Annen
Alvin W. Annen
HLHui Li
Hui Li
MZMartin T. Zanni
Martin T. Zanni
Potassium channels are responsible for the selective permeation of K + ions across cell membranes. K + ions permeate in single file through the selectivity filter, a narrow pore lined by backbone carbonyls that compose four K + binding sites. Here, we report on the two-dimensional infrared (2D IR) spectra of a semisynthetic KcsA channel with site-specific heavy ( 13 C 18 O) isotope labels in the selectivity filter. The ultrafast time resolution of 2D IR spectroscopy provides an instantaneous snapshot of the multi-ion configurations and structural distributions that occur spontaneously in the filter. Two elongated features are resolved, revealing the statistical weighting of two structural conformations. The spectra are reproduced by molecular dynamics simulations of structures with water separating two K + ions in the binding sites, ruling out configurations with ions occupying adjacent sites.

16 April 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
MSMarion Schuller
Marion Schuller
GCGalen J. Correy
Galen J. Correy
SGStefan Gahbauer
Stefan Gahbauer
DFDaren Fearon
Daren Fearon
TWTaiasean Wu
Taiasean Wu
IAIvan Ahel
Ivan Ahel
Massive fragment screening effort provides a foundation for the development of macrodomain inhibitors as novel antiviral agents.

30 July 2018 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
SZShao-Qing Zhang
Shao-Qing Zhang
HHHai Huang
Hai Huang
JYJunjiao Yang
Junjiao Yang
HKHuong T. Kratochvil
Huong T. Kratochvil
MLMarco Lolicato
Marco Lolicato
WDWilliam F. DeGrado
William F. DeGrado

12 June 2023 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
HKHuong T. Kratochvil
Huong T. Kratochvil
LWLaura C. Watkins
Laura C. Watkins
MMMarco Mravic
Marco Mravic
JTJessica L. Thomaston
Jessica L. Thomaston
JNJohn M. Nicoludis
John M. Nicoludis
WDWilliam F. DeGrado
William F. DeGrado